Chemotherapy with mitoxantrone in hormone-refractory prostate cancer

Comment

A E Denes. J Clin Oncol. 1997 Jan.

. 1997 Jan;15(1):410-1.

doi: 10.1200/JCO.1997.15.1.410.

No abstract available

Comment on

One hundred thirteen men with hormone-refractory prostate cancer died today.
Vogelzang NJ. Vogelzang NJ. J Clin Oncol. 1996 Jun;14(6):1753-5. doi: 10.1200/JCO.1996.14.6.1753. J Clin Oncol. 1996. PMID: 8656242 No abstract available.
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM, Murphy KC. Tannock IF, et al. J Clin Oncol. 1996 Jun;14(6):1756-64. doi: 10.1200/JCO.1996.14.6.1756. J Clin Oncol. 1996. PMID: 8656243 Clinical Trial.